NFKB1 and infection: Existing studies have found that NAD (nicotinamide adenine dinucleotide) can promote the secretion of intestinal mucin 2 (MUC2), enhance the ability of antibacterial infection, and alleviate intestinal inflammation by inhibiting NF-kB.